Meet us at the 14th International Symposium on Antimicrobial Agents and Resistance (ISAAR) & 2024 Annual Conference of the Korean Society of Antimicrobial Therapy (KSAT) at the Grand InterContinental Seoul Parnas from April 8 to 10, 2024.

The conference contemplates post-pandemic issues in infectious disease such as:

  • Emerging pathogens and Multidrug-Resistant Organisms (MDROs)
  • Antimicrobial stewardship
  • Vaccination programs
  • New diagnostic technologies
  • Antimicrobial agent development
  • Advances in microbiome research
  • Impact of climate, geo-political and economic conditions
  • Artificial intelligence in infectious disease

As we experienced during the pandemic (and since) rapid, reliable, but comprehensive testing is necessary for accurate identification of known and novel pathogens.  We believe metagenomic Next-Generation Sequencing (mNGS) could be a universal tool for the study, testing, treatment and surveillance of infectious diseases. That’s why we develop mNGS-enabling products from sample collection to definitive action.  

All-in-one Test

Our Pathogen Real-Time Identification by Sequencing (PaRTI-Seq™) assay is unique because it includes:

  • Zwitterionic host depletion 
  • mNGS-grade reagents for microbial enrichment  
  • Ultra low DNA input library kits
  • Specialized bioinformatics
PaRTI-Seq Collection to Action Disease diagnostics kit

PaRTI-Seq delivers:

  • >99% nucleated host cell depletion
  • >90% microbial passing efficiency
  • 10 – 1000 fold microbial enrichment 
  • Produces high-quality, high diagnostic-yield genomic DNA
  • Pathogen identification in 5 million reads (100bp)
  • Antimicrobial resistant gene profiling in 20-25 million reads

Set up time with us to talk about how you can use mNGS for your next project.

April 8 (Mon) – April 10 (Wed), 2024

Grand InterContinental Seoul Parnas